Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,326 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies.
Wang CH, Hwang Y, Lin E. Wang CH, et al. J Exp Pharmacol. 2010 Jun 23;2:73-82. doi: 10.2147/jep.s8655. eCollection 2010. J Exp Pharmacol. 2010. PMID: 27186094 Free PMC article. Review.
Effect of the common -866G/A polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese Taiwanese population.
Hsiao TJ, Wu LS, Hwang Y, Huang SY, Lin E. Hsiao TJ, et al. Mol Diagn Ther. 2010 Apr 1;14(2):101-6. doi: 10.1007/BF03256359. Mol Diagn Ther. 2010. PMID: 20359253
Pattern-recognition techniques with haplotype analysis in pharmacogenomics.
Lin E, Hwang Y, Liang KH, Chen EY. Lin E, et al. Pharmacogenomics. 2007 Jan;8(1):75-83. doi: 10.2217/14622416.8.1.75. Pharmacogenomics. 2007. PMID: 17187511 Review.
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
Hwang Y, Chen EY, Gu ZJ, Chuang WL, Yu ML, Lai MY, Chao YC, Lee CM, Wang JH, Dai CY, Shian-Jy Bey M, Liao YT, Chen PJ, Chen DS. Hwang Y, et al. Pharmacogenomics. 2006 Jul;7(5):697-709. doi: 10.2217/14622416.7.5.697. Pharmacogenomics. 2006. PMID: 16886895
3,326 results
Jump to page
Feedback